Rainbow Childrens Medicare logo

Rainbow Childrens Medicare

RAINBOW NSE

Key Fundamentals

MicrocapHospitalsHealthcare Services
Market Cap
₹14,646 Cr
Volatility
Moderate
P/E Ratio
51.42
EBITDA
₹588 Cr
Return on Equity
16.92%
Debt to Equity
0.54
Book Value
₹164.36
EPS
₹21.23
52W High
₹1,610
52W Low
₹1,084

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company's median sales growth is 22.8% of last 10 years

Weaknesses

1
  • Stock is trading at 8.90 times its book value

Growth Rate

Revenue Growth
11.49% lower than 3Y
Net Income Growth
15.27% higher than 3Y
Cash Flow Change
6.07% lower than 3Y
ROE
2.17% lower than 3Y
ROCE
-6.86% lower than 3Y
EBITDA Margin (Avg.)
-2.49% higher than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk high

Rainbow Childrens Medicare Ltd is a pediatric hospital chain with a market cap of ₹14,646 Cr trading at a PE of 51.1x and 9.0x book value. The company has delivered a 10-year sales CAGR of 22% and TTM revenue growth of 18%, though profit growth at 11% TTM is lagging revenue growth, and ROE has moderated to 16% in the last year from a 5-year average of 19%.

Bull Case 7
  • Strong long-term revenue track record with 10-year compounded sales growth of 22%, indicating consistent demand for pediatric healthcare services
  • TTM sales growth of 18% remains healthy and above the broader hospital sector average, suggesting continued operational momentum
  • 5-year compounded profit growth of 44% demonstrates significant operating leverage and margin expansion over the medium term
  • 10-year compounded profit growth of 31% reflects a durable earnings compounding trajectory over a full business cycle
  • Median sales growth of 22.8% over the last 10 years shows consistency in topline delivery without heavy reliance on one-off years
  • 3-year stock CAGR of 13% indicates the market has recognized the company's growth, building a track record of shareholder value creation
  • 5-year average ROE of 19% is respectable for a hospital business, suggesting efficient use of shareholder equity over the medium term
Bear Case 8
  • PE ratio of 51.1x is elevated, pricing in significant future growth and leaving little margin of safety if execution falters
  • Stock trades at 9.0x book value, well above hospital sector norms, making the valuation vulnerable to any earnings disappointment
  • TTM profit growth of 11% is materially lagging TTM sales growth of 18%, suggesting possible margin pressure or rising costs
  • 3-year compounded profit growth of only 6% is notably weak relative to the 3-year sales CAGR of 13%, indicating earnings have not kept pace with revenue expansion recently
  • ROE has declined from a 5-year average of 19% to 16% in the last year, pointing to diminishing return efficiency as the company scales
  • 1-year stock return of -2% shows the market has de-rated the stock despite continued revenue growth, reflecting valuation concerns
  • Dividend yield of just 0.24% offers minimal income cushion, meaning returns are almost entirely dependent on capital appreciation
  • The niche focus on pediatric and perinatal care, while a competitive moat, limits the addressable market compared to multi-specialty hospital chains

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Headwinds 1
  • Two senior exits in one week Aug 25

    CFO Vikas Maheshwari resigned effective Aug 31, 2026, followed by Chief Strategy & Growth Officer Srinath Metla's resignation on Aug 31 with relief date Sep 5, 2026. Back-to-back C-suite departures raise concerns about leadership stability and strategic continuity.

Neutral 2
  • CFO resignation, replacement pending Aug 25

    CFO Vikas Maheshwari stepped down citing personal reasons, effective close of business Aug 31, 2026. The board is finalizing a replacement candidate.

  • Strategy officer Metla exits Aug 31

    Chief Strategy and Growth Officer Srinath Metla resigned citing personal reasons. He will be relieved from duties on Sep 5, 2026.

TL;DR: Rainbow Childrens Medicare faces near-term leadership uncertainty after losing both its CFO and Chief Strategy & Growth Officer within a single week in late August 2026. Both cited personal reasons, and no successor has been announced for either role yet. While individual resignations are routine, the clustering of two key departures warrants monitoring. Investors should watch for timely appointments and any impact on the company's growth strategy execution.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
287
333
336
341
330
417
398
370
353
445
445
460
470
Expenses
199
215
218
236
236
270
264
255
249
296
298
315
335
Operating Profit
88
118
118
106
94
147
134
115
104
149
147
145
135
OPM %
31%
35%
35%
31%
28%
35%
34%
31%
29%
33%
33%
31%
29%
Other Income
8
8
9
13
12
11
13
15
20
8
11
4
13
Interest
15
13
14
17
18
18
18
18
18
19
20
20
21
Depreciation
25
27
28
32
34
35
35
34
34
36
40
41
42
PBT
56
85
85
69
53
105
94
77
71
102
98
87
84
Tax %
25%
26%
26%
26%
26%
25%
27%
27%
25%
26%
24%
10%
26%
Net Profit
42
63
63
51
40
79
69
57
54
76
74
78
63
EPS in Rs
4.04
6.2
6.12
5.02
3.89
7.77
6.76
5.55
5.27
7.41
7.14
7.59
5.96
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
169
234
321
402
543
719
650
974
1,174
1,297
1,516
1,703
1,820
Expenses
128
204
266
332
391
519
485
666
774
865
1,022
1,155
1,245
Operating Profit
41
30
55
69
151
201
165
308
400
432
494
548
575
OPM %
24%
13%
17%
17%
28%
28%
25%
32%
34%
33%
33%
32%
32%
Other Income
10
16
11
10
8
10
10
19
31
37
51
42
35
Interest
3
3
3
4
42
48
46
56
58
63
77
82
81
Depreciation
9
18
22
28
60
69
73
83
90
112
138
151
159
PBT
38
24
41
47
58
93
56
187
282
295
330
358
371
Tax %
35%
28%
24%
22%
22%
41%
29%
26%
25%
26%
26%
21%
—
Net Profit
25
17
31
36
45
55
40
139
212
218
244
282
290
EPS in Rs
26.74
18.22
33.78
8.25
10.14
12.68
9.1
14.7
20.77
21.38
23.97
27.4
28.1
Div. Payout %
7%
11%
7%
12%
10%
16%
0%
14%
14%
14%
13%
13%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9
9
9
44
44
44
44
94
102
102
102
102
Reserves
166
275
308
307
317
350
391
498
958
1,157
1,367
1,547
Borrowings
22
24
26
24
476
501
529
592
570
765
764
891
Other Liabilities
34
41
55
73
89
123
116
112
140
146
145
236
Total Liabilities
231
349
399
448
926
1,019
1,081
1,296
1,771
2,170
2,377
2,775
Fixed Assets
78
123
174
296
702
702
772
858
931
1,253
1,398
1,756
CWIP
35
31
7
12
23
43
29
6
23
20
28
79
Investments
7
2
6
0
3
10
18
22
58
308
571
404
Other Assets
111
194
212
140
199
265
262
409
759
590
380
535
Total Assets
231
349
399
448
926
1,019
1,081
1,296
1,771
2,170
2,377
2,775
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
26
17
36
48
127
170
143
224
329
321
396
420
Investing
-20
-107
-33
-42
-117
-117
-83
-175
-465
-226
-268
-259
Financing
-7
93
-1
-7
-9
-52
-61
-44
143
-102
-118
-147
Net Cash Flow
-1
3
1
-2
2
2
-1
4
7
-7
10
14
Free Cash Flow
-35
-46
-21
-103
42
96
67
162
188
-32
250
204
CFO/OP
95
88
79
88
94
95
102
93
103
95
97
95
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
11
10
16
14
24
22
25
15
16
20
19
22
Inventory Days
39
35
48
36
32
55
36
28
43
53
52
67
Days Payable
121
107
142
151
197
202
190
121
182
180
170
162
Cash Conversion Cycle
-72
-62
-79
-100
-141
-124
-130
-78
-123
-107
-100
-73
Working Capital Days
-35
-36
-28
-31
-26
-18
-17
-16
73
43
19
8
ROCE %
22%
11%
14%
14%
16%
16%
11%
23%
24%
19%
19%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Rainbow Childrens Medicare insights

62 extracted metrics + investor summaries across FY15–FY27.

Log in — free

Shareholding Pattern

Others1.16%Promot.49.84%Public10.41%FIIs16.03%DIIs22.56%As ofJun 2026

Documents

Frequently Asked Questions about Rainbow Childrens Medicare

What does Rainbow Childrens Medicare Ltd do?
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gy...
Where is Rainbow Childrens Medicare Ltd (RAINBOW) listed?
Rainbow Childrens Medicare Ltd trades as RAINBOW on the NSE and under code 543524 on the BSE.
Which sector does Rainbow Childrens Medicare Ltd belong to?
Rainbow Childrens Medicare Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Rainbow Childrens Medicare Ltd?
Rainbow Childrens Medicare Ltd has a market capitalisation of ₹14,646 Cr, which places it in the Mid Cap band.
What is the PE ratio of Rainbow Childrens Medicare Ltd?
Rainbow Childrens Medicare Ltd trades at a PE ratio of 51.42, on earnings per share of ₹21.23, against a book value of ₹164.36 per share.
What is the 52-week high and low of Rainbow Childrens Medicare Ltd?
Over the last 52 weeks Rainbow Childrens Medicare Ltd has traded between ₹1,084 and ₹1,610.
Does Rainbow Childrens Medicare Ltd pay dividends?
Rainbow Childrens Medicare Ltd has a dividend yield of 0.24%.
What is the Return on Equity (ROE) of Rainbow Childrens Medicare Ltd?
Rainbow Childrens Medicare Ltd reported a return on equity of 16.92%. Its debt-to-equity ratio is 0.54.

Company Information

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

Website rainbowhospitals.in
Listed 2022-05-10
Face Value ₹ 10
Issued Size 10,15,59,156

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/RAINBOW.md for Rainbow Childrens Medicare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List